Legal Challenges Facing Prescriptive Authority for Clinical Psychologists in South Africa: Current Issues and Controversies

Prescription privileges for psychologists (RxP) refer to the ability of appropriately trained psychologists to prescribe psychotropic medications to their patients. There are clear arguments that support or dismiss treatment privilege for psychologists. The movement for prescription privileges for psychologists has been a gradual and ongoing process, with significant progress made in recent decades. The field of psychologist prescribing is still relatively new, and more research is needed to fully understand its impact on patient care. However, the available evidence suggests that prescribing psychologists can provide safe and effective mental healthcare. At present, prescribing rights for psychologists are being considered in Canada, the United Kingdom, and Australia. In most Latin American countries, clinical psychologists are not legally authorized to prescribe medication. In the exception of a few countries, such as Mexico and Brazil. In South Africa, the Health Professions Council of South does not authorize clinical psychologists to prescribe psychotropic medication. The American Psychological Association (APA) has indeed played a significant role in the movement to grant prescription privileges to psychologists. In 2011, the APA published a comprehensive set of practice guidelines for psychologists involved in pharmacotherapy. In this paper review of countries that have facilitated or are in the process of doing so are reviewed. The legislation governing the profession of psychologists in relation to prescriptive authority in South Africa is reviewed and recommendations made. The psychologists in South Africa will have to address the misconceptions and legal ramifications in similar ways as the USA in order to get acceptance.